I-MAB Biopharma
Latest round
- Series C
Last raised
- Jun 2018
Total raised
- $380M
Investors
- 10
About I-MAB Biopharma
Founded in 2014 and headquartered in Rockville, US, I-MAB Biopharma specializes in the R&D of precision immuno-oncology agents for the treatment of cancer. In January 2020, it was listed on NASDAQ under the ticker IMAB. I-MAB Biopharma engages in the R&D of novel therapeutics across oncology, autoimmune disorders, and metabolic diseases. Its portfolio includes immunoglobulin Fc-fusion polypeptides for diabetes treatment, GLP-1 analogues for blood glucose reduction, and multiple immuno-oncology drug candidates aimed at enhancing cancer treatment outcomes. The company integrates in-house discovery with external partnerships to advance first-in-class and best-in-class biologics. The company generates revenue from collaborative licensing agreements, R&D partnerships, milestone payments, and future sales of proprietary biologic drug candidates.
Who invested in I-MAB Biopharma
10 investors across 3 rounds
See all investors in I-MAB Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about I-MAB Biopharma
Who invested in I-MAB Biopharma?
I-MAB Biopharma has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has I-MAB Biopharma raised?
I-MAB Biopharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did I-MAB Biopharma last raise money?
I-MAB Biopharma's most recent round on record is a Series C, in Jun 2018.
What does I-MAB Biopharma do?
Founded in 2014 and headquartered in Rockville, US, I-MAB Biopharma specializes in the R&D of precision immuno-oncology agents for the treatment of cancer.
Where is I-MAB Biopharma headquartered?
I-MAB Biopharma is headquartered in Rockville, US.
Which VCs invest in companies like I-MAB Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at I-MAB Biopharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like I-MAB Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.